top of page
Companies in the News
Ring Therapeutics Raises $86.5M in Series C Funding to Create Next Generation Programmable Medicines
Ring raised a total of $86.5 million from new and returning investors, validating its unique approach to creating next-generation...
Mar 10, 2023
Aera Therapeutics Launches with $193 M for the Next Generation of Transformative Genetic Medicines
Proprietary delivery platform, based on endogenous human proteins, offers the potential to enable genetic medicines across a broad range...
Feb 16, 2023
Tessera Therapeutics Highlights Advancements Across its Gene Writing™ and Delivery Platforms
RNA Gene Writing™ platform demonstrates clinically relevant levels of in vivo rewriting in the genome of liver cells of non-human...
Jan 9, 2023
eFFECTOR Therapeutics Provides Positive Clinical Data Update for Zotatifin
Zotatifin continues to show favorable activity profile, including two confirmed partial responses (PR) among seven heavily pretreated...
Jan 6, 2023
DNA Writing Goes Enzymatic, Encourages Pursuit of Bold Visions
The 1950s are widely recognized as one of the most important decades in biology. This is, in large part, due to the discovery of the...
Dec 21, 2022
Nuvation Bio Doses First Patient in Phase 1b Combination Study of NUV-868
Phase 1b study designed to determine the safety and dose of NUV-868 in combination with olaparib or enzalutamide for the treatment of...
Dec 19, 2022
Federation Bio Administers First Dose in Phase 1 Clinical Trial
- Study will assess the safety, efficacy and engraftment of FB-001 for the treatment of enteric hyperoxaluria, a serious metabolic...
Dec 8, 2022
Escient Pharmaceuticals Announces $120 Million Series C Financing
Financing led by New Enterprise Associates (NEA), Abingworth and Forge Life Science Partners Proceeds support advancement of EP262 and...
Nov 28, 2022
Indigo Expands 2023 Biological Crop Protection Line with New Biofungicide
MEMPHIS, Tenn., Nov. 22, 2022 /PRNewswire/ -- Indigo Agriculture today announced the commercial launch of the industry's first biological...
Nov 23, 2022
bottom of page